Eupatilin

Product ID E8260

Cas No. 22368-21-4

Purity ≥98%

Unit Size	Cost	Quantity		Stock

Bulk Quote

Add to Wishlist

Quicklinks

Description
Product Info
Shipping and Storage
Downloads
References

Description
Product Info
Shipping and Storage
Downloads
References
Custom Order

Description

Eupatilin is an O-methylated flavone found in Artemisia; it exhibits anticancer chemotherapeutic, nephroprotective, anti-inflammatory, anti-arthritic, antinociceptive, gastrointestinal motility modulating, antidepressant, antioxidative, neuroprotective, and anti-angiogenic activities. In gastric cancer cells, eupatilin suppresses cell growth; in animal models of gastric cancer, eupatilin inhibits STAT3 and VEGF expression and decreases tumor growth. This compound activates PPARα and ameliorates kidney injury in models of renal ischemia/reperfusion. Additionally, eupatilin inhibits cartilage degradation, decreases nociception, and downregulates expression of IL-6, iNOS, and IL-1β in animal models of osteoarthritis. Eupatilin also slows gastrointestinal motility in animal models, protects against cerebral ischemia/reperfusion-induced neuronal damage, and decreases immobility time in animals undergoing the forced swim test.

Product Info

Cas No.	22368-21-4
Purity	≥98%
Formula	C₁₈H₁₆O₇
Formula Wt.	344.32
Chemical Name	2-(3,4-Dimethoxyphenyl)-5,7-dihydroxy-6-methoxy-4H-chromen-4-one
IUPAC Name	2-(3,4-Dimethoxyphenyl)-5,7-dihydroxy-6-methoxy-4H-chromen-4-one
Synonym	NSC 122413; Stillen
Solubility	Soluble in DMSO, hot methanol or mixture of methanol and chloroform.
Appearance	Pale yellow powder.

Shipping and Storage

Store Temp	-20°C
Ship Temp	Ambient

Downloads

MSDS	E8260 MSDS PDF
Info Sheet	E8260 Info Sheet PDF

References

Choi Y, Jung Y, Kim SN. Identification of Eupatilin from Artemisia argyi as a Selective PPARα Agonist Using Affinity Selection Ultrafiltration LC-MS. Molecules. 2015 Jul 28;20(8):13753-63. PMID: 26225954.

Jeong JH, Moon SJ, Jhun JY, et al. Eupatilin Exerts Antinociceptive and Chondroprotective Properties in a Rat Model of Osteoarthritis by Downregulating Oxidative Damage and Catabolic Activity in Chondrocytes. PLoS One. 2015 Jun 17;10(6):e0130882. PMID: 26083352.

Jeong HJ, Kim JH, Kim NR, et al. Antidepressant effect of Stillen. Arch Pharm Res. 2015 Jun;38(6):1223-31. PMID: 25163682.

Jeong EK, Jang HJ, Kim SS, et al. Protective effect of eupatilin against renal ischemia-reperfusion injury in mice. Transplant Proc. 2015 Apr;47(3):757-62. PMID: 25891726.

Ryoo SB, Oh HK, Yu SA, et al. The effects of eupatilin (stillen®) on motility of human lower gastrointestinal tracts. Korean J Physiol Pharmacol. 2014 Oct;18(5):383-90. PMID: 25352757.

Park BB, Yoon Js, Kim Es, et al. Inhibitory effects of eupatilin on tumor invasion of human gastric cancer MKN-1 cells. Tumour Biol. 2013 Apr;34(2):875-85. PMID: 23292941.

Lim JC, Park SY, Nam Y, et al. The Protective Effect of Eupatilin against Hydrogen Peroxide-Induced Injury Involving 5-Lipoxygenase in Feline Esophageal Epithelial Cells. Korean J Physiol Pharmacol. 2012 Oct;16(5):313-20. PMID: 23118554.

Cai M, Phan PT, Hong JG, et al. The neuroprotective effect of eupatilin against ischemia/reperfusion-induced delayed neuronal damage in mice. Eur J Pharmacol. 2012 Aug 15;689(1-3):104-10. PMID: 22683875.

Cheong JH, Hong SY, Zheng Y, et al. Eupatilin Inhibits Gastric Cancer Cell Growth by Blocking STAT3-Mediated VEGF Expression. J Gastric Cancer. 2011 Mar;11(1):16-22. PMID: 22076197.